A Boston-based pharmaceutical company has decided to drop its patent lawsuit against Moderna regarding the company’s widely used coronavirus vaccines. This decision comes after an unfavorable claim construction ruling by Delaware’s leading judge, marking another instance of the developer stepping back from legal challenges against the vaccine manufacturer. This recent development continues a pattern of legal setbacks faced by the Boston firm.
For further details, the initial report can be accessed via Law360. These developments could have far-reaching implications on the ongoing legal landscape surrounding COVID-19 vaccine patents.